1[1]Duprez DA.Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation:a clinical review[J].J Hypertens,2006,24:983-991.
2[2]Sakata K,Yoshida K,Obayashi K,et al.Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension[J].Journal of Hypertension,2002,20:103-110.
3[3]Yagi S,Morita T,Katayama S.Combined treatment with an ATⅠ receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress[J].Hypertens Res,2004,27:129-135.
6[6]Doulton TW,He FJ,MacGregor GA.Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension[J].Hypertension,2005,45:880-886.
7[8]Tanemoto M,Abe T,Obara N,et al.Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin Ⅱ receptor blocker[J].Hypertens Res,2003,26:863-868.
8[9]Scaglione R,Argano C,Corrao S,et al.Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitot and angiotensin Ⅱ receptor in hypertensive subjects with minor renal abnormalities:a 24-week randomized controlled trial[J].J Hypertens,2005,23:657-664.
9[10]Ferrari P,Marti HP,Pfister M,et al.Additive antiproteinuric effect of combined ACE inhibition and angiotensin Ⅱ receptor blockade[J].Journal of Hypertension,2002,20:125-130.
10[11]Anan F,Takahashi N,Ooie T,et al.Effects of valsartan and perindopril combination therapy on left ventricular hypertension and aortic arterial stiffness in patients with essential hyperten sion[J].Eur J Clin Pharmacol,2005,61:353-359.
2Azizi M,Guyene TT,Charellier G,et al.Additive effects of valsartan and enalapril on blood pressure and plasma active renin[J].Hypertens,1997,29:634-640.
3Ke YS,Cao H,Yang T.Effect of combination of valsartan with benazepril on blood pressure and 1 eft ventricular hypertrophy in SHR[J].Acta Pharmacol Sin,2000,21(11):1043-1047.
4Lee S,Kramer CM,Mankad S,et al.Combined angiotensin convening enzyme inhibition and angiotensin AT 1 receptor blockade up-regulates myocardial AT2 receptors in remodeled myocardiun post-infarction[J].Cardioivasc Res,2001,51(1):131-139.
5[1]Stanley S,Franklin M D,Shehzad D,et al.Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study[J].Circulation,1999,100(4):354-360.
6[2]Mansoor G A,Massie B M.Left ventricular hypertrophy:a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure[J].Blood Pressure Monit,1999,4(Suppl 1):19-22.
7[3]Devereux R B,Alonso D R,Lutas E M,et al.Echocardiography assessment of left ventricular hypertrophy:comparison to necropsy findings[J].Am J Cardiol,1986,57(6):450-458.
8[4]Zakopoulos N A,Lekakis J P,Papamichael C M,et al.Pulse pressure in normotensive:a marker of cardiovascular disease[J].Am J Hypertension,2001,14(3):195-199.
9[6]Mitchell G F,Moye L A,Braunwald E,et al.Sphygmomanometer determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function[J].Circulation,1997,96(12):4254-4260.
10[7]Benetos A,Rudnichi A,Safar M,et al.Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects[J].Hypertension,1998,32(3):560-564.
7Haffner SM, Gonzalez C, Miettinen H, et al. A prospective analysis of the Homa model: The Mexico City diabetes study [ J ]. Diabetes Care, 1996, 19(10) :1138 -1141.
8Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[ J]. Lancet, 1992, 340 (8828) : 1111 - 1115.
9Hsueh WA, Lyon C J, Quinones M J, et al. Insulin resistance and the Endothelium[ J]. Am J Med, 2004, 117(2) :109 -117.
10Cheetham C, Collis J, O'Driscoll G, et al. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes[J]. J Am Coll Cardiol, 2000, 36(5) :1461 - 1466.
